EE03829B1 - Bensonaftüridiinid, nende kasutamine bronhiaalravimi valmistamiseks ning neid sisaldav ravim - Google Patents

Bensonaftüridiinid, nende kasutamine bronhiaalravimi valmistamiseks ning neid sisaldav ravim

Info

Publication number
EE03829B1
EE03829B1 EEP199900105A EE9900105A EE03829B1 EE 03829 B1 EE03829 B1 EE 03829B1 EE P199900105 A EEP199900105 A EE P199900105A EE 9900105 A EE9900105 A EE 9900105A EE 03829 B1 EE03829 B1 EE 03829B1
Authority
EE
Estonia
Prior art keywords
benzonaphthyridines
medicament
manufacture
product containing
medicinal product
Prior art date
Application number
EEP199900105A
Other languages
English (en)
Estonian (et)
Other versions
EE9900105A (et
Inventor
Gutterer Beate
Amschler Hermann
Ulrich Wolf-R�diger
Martin Thomas
B�r Thomas
Hatzelmann Armin
Sanders Karl
Beume Rolf
Boss Hildegard
H�fner Dietrich
Kley Hans-Peter
Goebel Karl-Josef
Original Assignee
Byk Gulden Lomberg Chemische Fabrik Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chemische Fabrik Gmbh filed Critical Byk Gulden Lomberg Chemische Fabrik Gmbh
Publication of EE9900105A publication Critical patent/EE9900105A/xx
Publication of EE03829B1 publication Critical patent/EE03829B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EEP199900105A 1996-11-11 1997-11-05 Bensonaftüridiinid, nende kasutamine bronhiaalravimi valmistamiseks ning neid sisaldav ravim EE03829B1 (et)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19646298 1996-11-11
EP96118188 1996-11-13
DE19739056 1997-09-05
PCT/EP1997/006096 WO1998021208A1 (fr) 1996-11-11 1997-11-05 Benzonaphtyridines en tant que agents therapeutiques bronchiques

Publications (2)

Publication Number Publication Date
EE9900105A EE9900105A (et) 1999-10-15
EE03829B1 true EE03829B1 (et) 2002-08-15

Family

ID=27216810

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP199900105A EE03829B1 (et) 1996-11-11 1997-11-05 Bensonaftüridiinid, nende kasutamine bronhiaalravimi valmistamiseks ning neid sisaldav ravim

Country Status (31)

Country Link
US (1) US6008215A (fr)
EP (1) EP0937074B1 (fr)
JP (1) JP4223075B2 (fr)
KR (1) KR100484045B1 (fr)
CN (1) CN1090188C (fr)
AT (1) ATE234300T1 (fr)
AU (1) AU733129B2 (fr)
BG (1) BG63695B1 (fr)
BR (1) BR9713338B1 (fr)
CA (1) CA2270964C (fr)
CY (1) CY2476B1 (fr)
CZ (1) CZ288752B6 (fr)
DE (1) DE69719778T2 (fr)
DK (1) DK0937074T3 (fr)
EA (1) EA001551B1 (fr)
EE (1) EE03829B1 (fr)
ES (1) ES2195189T3 (fr)
GE (1) GEP20012390B (fr)
HK (1) HK1022151A1 (fr)
HU (1) HU226981B1 (fr)
ID (1) ID22042A (fr)
IL (1) IL129054A (fr)
NO (1) NO312764B1 (fr)
NZ (1) NZ334976A (fr)
PL (1) PL189641B1 (fr)
PT (1) PT937074E (fr)
RS (1) RS49607B (fr)
SI (1) SI0937074T1 (fr)
SK (1) SK283269B6 (fr)
TR (1) TR199900856T2 (fr)
WO (1) WO1998021208A1 (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2195571T3 (es) 1998-05-05 2003-12-01 Altana Pharma Ag Nuevos benzonaftiridin-n-oxidos.
ATE269331T1 (de) 1998-08-31 2004-07-15 Altana Pharma Ag Benzonaphthyridin-n-oxide mit pde3 und pde4 inhibierender aktivität
IT1303272B1 (it) * 1998-10-29 2000-11-06 Zambon Spa Derivati triciclici inibitori della fosfodiesterasi 4
ATE294793T1 (de) 1999-01-15 2005-05-15 Altana Pharma Ag Phenantrhridin-n-oxides mit pde-iv hemmender wirkung
CA2359440C (fr) * 1999-01-15 2009-04-14 Beate Gutterer Phenylphenanthridines a activite inhibitrice de pde iv
SI1147087T1 (en) 1999-01-15 2005-10-31 Altana Pharma Ag Phenanthridine-n-oxides with pde-iv inhibiting activity
WO2000042018A1 (fr) * 1999-01-15 2000-07-20 Byk Gulden Lomberg Chemische Fabrik Gmbh 6-phenylphenanthridines polysubstitues a activite inhibant pde-iv
CA2715683A1 (fr) * 1999-08-21 2001-03-01 Nycomed Gmbh Combinaison synergiste
NL1017973C2 (nl) * 2000-05-10 2002-11-08 Tristem Trading Cyprus Ltd Inrichting.
WO2002066476A1 (fr) * 2001-02-21 2002-08-29 Altana Pharma Ag 6-phenylbenzonaphtyridines
US6479493B1 (en) 2001-08-23 2002-11-12 Cell Pathways, Inc. Methods for treatment of type I diabetes
PL373598A1 (en) * 2002-08-17 2005-09-05 Altana Pharma Ag Novel benzonaphthyridines
US7470704B2 (en) 2002-09-04 2008-12-30 Nycomed Gmbh Benzonaphthyridines
DE60313331T2 (de) * 2002-09-04 2008-01-03 Nycomed Gmbh Neue benzonaphthyridine
CN104817534A (zh) 2004-03-03 2015-08-05 塔科达有限责任公司 新的羟基-6-杂芳基菲啶及其作为pde4抑制剂的用途
AR049419A1 (es) * 2004-03-03 2006-08-02 Altana Pharma Ag Hidroxi-6-fenilfenantridinas sustituidas con heterociclilo
MXPA06009892A (es) * 2004-03-10 2007-03-01 Altana Pharma Ag Nuevas hidroxi-6-fenilfenantridinas sustituidas con amido y su uso como inhibidores de la fosfodiesterasa tipo 4 (pde4).
US7671068B2 (en) 2004-03-17 2010-03-02 Nycomed Gmbh N-(alkoxyalkyl) carbamoyl-substituted 6-phenyl-benzonaphthyridine derivatives and their use as PDE ¾ inhibitors
US7589205B2 (en) 2004-09-08 2009-09-15 Nycomed Gmbh 3-thia-10-aza-phenanthrene derivatives
WO2006027344A2 (fr) * 2004-09-08 2006-03-16 Altana Pharma Ag Nouvelles 3-oxa-10-aza-phenanthrenes
NZ560268A (en) 2005-03-02 2010-12-24 Nycomed Gmbh Novel salts of 6-heterocyclyl substituted hexahydrophenanthridine derivatives
US20090221664A1 (en) 2005-10-19 2009-09-03 Abhijit Ray Pharmaceutical compositions of muscarinic receptor antagonists
TW200808695A (en) * 2006-06-08 2008-02-16 Amgen Inc Benzamide derivatives and uses related thereto
CA2974246C (fr) * 2006-09-01 2020-02-25 Senhwa Biosciences, Inc. Composes heteroaryles tricycliques et leur utilisation comme modulateursde proteine
ES2552549T3 (es) 2008-04-23 2015-11-30 Rigel Pharmaceuticals, Inc. Compuestos de carboxamida para el tratamiento de trastornos metabólicos
AR079451A1 (es) 2009-12-18 2012-01-25 Nycomed Gmbh Compuestos 3,4,4a,10b-tetrahidro-1h-tiopirano[4,3-c]isoquinolina
CN108299429B (zh) * 2018-04-09 2021-10-08 中南大学 一类八氢苯并萘啶化合物及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3899494A (en) * 1970-05-13 1975-08-12 Sandoz Ltd Substituted 6-phenyl benzo-naphthyridines
EP0247971A3 (fr) * 1986-05-29 1990-01-17 Sandoz Ag Compositions pharmaceutiques contenant de la cis-6-(4-acétanilido)-8,9-diméthoxy-2-méthyl-1,2,3,4,4a,10b-hexahydrobenzo[c][1,6]naphtyridine et son utilisation
MY105344A (en) * 1990-05-16 1994-09-30 Byk Gulden Lomberg Chemische Fabrik New sulphonyl compounds

Also Published As

Publication number Publication date
PL333429A1 (en) 1999-12-06
HK1022151A1 (en) 2000-07-28
KR20000053100A (ko) 2000-08-25
BR9713338B1 (pt) 2009-12-01
YU19499A (sh) 2001-09-28
EA199900421A1 (ru) 1999-10-28
CN1236367A (zh) 1999-11-24
PT937074E (pt) 2003-07-31
CA2270964C (fr) 2007-07-31
CZ167599A3 (cs) 1999-11-17
EP0937074B1 (fr) 2003-03-12
BR9713338A (pt) 2000-05-09
HU226981B1 (hu) 2010-04-28
JP2001503442A (ja) 2001-03-13
SK283269B6 (sk) 2003-04-01
NO312764B1 (no) 2002-07-01
SK62399A3 (en) 1999-10-08
KR100484045B1 (ko) 2005-04-20
CA2270964A1 (fr) 1998-05-22
IL129054A0 (en) 2000-02-17
EA001551B1 (ru) 2001-04-23
ES2195189T3 (es) 2003-12-01
HUP0000426A3 (en) 2001-04-28
DK0937074T3 (da) 2003-06-23
GEP20012390B (en) 2001-03-25
ID22042A (id) 1999-08-26
HUP0000426A2 (hu) 2001-02-28
US6008215A (en) 1999-12-28
AU733129B2 (en) 2001-05-10
BG63695B1 (bg) 2002-09-30
JP4223075B2 (ja) 2009-02-12
SI0937074T1 (en) 2003-08-31
ATE234300T1 (de) 2003-03-15
IL129054A (en) 2002-07-25
CZ288752B6 (cs) 2001-08-15
EP0937074A1 (fr) 1999-08-25
DE69719778T2 (de) 2004-02-05
DE69719778D1 (de) 2003-04-17
TR199900856T2 (xx) 1999-07-21
CY2476B1 (en) 2005-05-03
NZ334976A (en) 2000-10-27
EE9900105A (et) 1999-10-15
WO1998021208A1 (fr) 1998-05-22
NO992282D0 (no) 1999-05-11
CN1090188C (zh) 2002-09-04
AU5317098A (en) 1998-06-03
PL189641B1 (pl) 2005-09-30
RS49607B (sr) 2007-06-04
BG103310A (en) 2000-05-31
NO992282L (no) 1999-05-11

Similar Documents

Publication Publication Date Title
EE03829B1 (et) Bensonaftüridiinid, nende kasutamine bronhiaalravimi valmistamiseks ning neid sisaldav ravim
SE9504661D0 (sv) New compounds
IT1276071B1 (it) Compositi ad attivita' anti-infiammatoria
EE9800223A (et) Fenantridiinid, neid sisaldavad ravimid ja nende kasutamine
ATE167470T1 (de) Heterocyclische amine zur therapie von asthma und entzündungen der atemwege
FI972628A (fi) Uudet sulfonamidit
ES2102475T3 (es) Nuevas alquil-amidas heterociclicas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
AU3563695A (en) Novel piperidine derivatives with paf antagonist activity
DE69315085D1 (de) 1,4-disubstituierte piperazine zur behandlung von asthma und entzündungen der atemwege
HK1019587A1 (en) Colchicine-skeleton compounds, their use as medicaments and compositions containing them
AU693241B2 (en) New 3-substituted 3h-2,3-benzodiazepine derivatives, their preparation and use as medicaments
SE9504662D0 (sv) New compounds
HUP0003612A2 (hu) Kinoxalin-dionok és ezeket tartalmazó gyógyászati készítmények
ES2187775T3 (es) Imidazopiridinas.
DK0805817T3 (da) Thiolderivater med metallopeptidaseinhiberende aktivitet
ATE141593T1 (de) Leukotrien-b 4?-derivative, verfahren zu ihrer herstellung und arzneimittel
NO305519B1 (no) Benzo[f]kinoksalindionderivater og legemidler inneholdende disse
IL117734A (en) Anellated beta-carbolines their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

HC1A Change of owner name
KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20091231

KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20151105